Isabel Hodl, Clarissa Sallegger, Patrick Forstner, Nazanin Sareban, Martina Moritz, Barbara Dreo, Eduard Schulz, Angelika Lackner, Barbara Kleinhappl, Stefan Hatzl, Florentine Moazedi-Fürst, Thomas Seifert-Held, Bettina Heschl, Michael Khalil, Christian Enzinger, Hildegard Greinix, Martin H Stradner, Ivo Steinmetz, Peter Schlenke, Johannes Fessler
B-cell depleting therapies result in diminished humoral immunity following vaccination against COVID-19, but our understanding on the impact on cellular immune responses is limited. Here, we performed a detailed analysis of cellular immunity following mRNA vaccination in patients receiving B-cell depleting therapy using ELISpot assay and flow cytometry. Anti-SARS-CoV-2 spike receptor-binding domain antibody assays were performed to elucidate B-cell responses. To complement our cellular analysis, we performed immunophenotyping for T- and B-cell subsets...
January 18, 2023: Microbes and Infection